SCHEMBL31593220

SCHEMBL31593220

CCOC(=O)CNCc1cnc(C(=O)Nc2cccc(-c3cccc(NC(=O)c4cc(C5CC5)c(CNCC(=O)OCC)cn4)c3C)c2C)cc1C1CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 20/20 1.00
▸ CD274 Q9NZQ7 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21229161 1.00 PDCD1 (1.00) PDCD1CD274
SCHEMBL22780051 0.97 PDCD1 (0.93) PDCD1CD274
SCHEMBL22769834 0.89 PDCD1 (1.00) PDCD1CD274
SCHEMBL22780075 0.88 PDCD1 (0.82) PDCD1CD274
SCHEMBL22780081 0.88 PDCD1 (0.78) PDCD1CD274
SCHEMBL22779808 0.87 PDCD1 (0.77) PDCD1CD274
SCHEMBL22769801 0.86 PDCD1 (0.85) PDCD1CD274
SCHEMBL22779975 0.85 PDCD1 (0.85) PDCD1CD274
SCHEMBL21229162 0.85 PDCD1 (0.85) PDCD1CD274
SCHEMBL21229397 0.85 PDCD1 (1.00) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750887-B1 BIARYL DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATION FOR THE TREATMENT OF PD-1/PD-L1 SIGNAL PATHWAY-MEDIATED DISEASES ABBISKO THERAPEUTICS CO LTD (CN) 2025-05-28 — — EP disclosed
Send feedback